Other OTC - Delayed Quote USD

Nanosonics Limited (NNCSF)

1.8500 -0.0200 (-1.07%)
At close: April 26 at 10:07 AM EDT
Key Events
Loading Chart for NNCSF
DELL
  • Previous Close 1.8700
  • Open 1.8500
  • Bid --
  • Ask --
  • Day's Range 1.8500 - 1.8500
  • 52 Week Range 1.8080 - 3.7750
  • Volume 250
  • Avg. Volume 501
  • Market Cap (intraday) 560.511M
  • Beta (5Y Monthly) 1.59
  • PE Ratio (TTM) 61.67
  • EPS (TTM) 0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

www.nanosonics.com.au

482

Full Time Employees

June 30

Fiscal Year Ends

Recent News: NNCSF

Performance Overview: NNCSF

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NNCSF
34.86%
S&P/ASX 200 [XJO]
0.20%

1-Year Return

NNCSF
46.53%
S&P/ASX 200 [XJO]
3.55%

3-Year Return

NNCSF
61.93%
S&P/ASX 200 [XJO]
7.53%

5-Year Return

NNCSF
43.25%
S&P/ASX 200 [XJO]
18.64%

Compare To: NNCSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NNCSF

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    543.48M

  • Enterprise Value

    473.26M

  • Trailing P/E

    55.73

  • Forward P/E

    66.23

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.27

  • Price/Book (mrq)

    4.92

  • Enterprise Value/Revenue

    2.86

  • Enterprise Value/EBITDA

    20.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.56%

  • Return on Assets (ttm)

    3.13%

  • Return on Equity (ttm)

    9.59%

  • Revenue (ttm)

    164.07M

  • Net Income Avi to Common (ttm)

    15.68M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    118.31M

  • Total Debt/Equity (mrq)

    6.07%

  • Levered Free Cash Flow (ttm)

    11.62M

Company Insights: NNCSF

People Also Watch